← Back to Clinical Trials
Recruiting NCT03561766

NCT03561766 Birth Cohort Study of China Medical University

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03561766
Status Recruiting
Phase
Sponsor Shengjing Hospital
Condition Twin; Complicating Pregnancy
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2018-06-15
Primary Completion 2020-06

Trial Parameters

Condition Twin; Complicating Pregnancy
Sponsor Shengjing Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2018-06-15
Completion 2020-06

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The CMUBCS is a birth cohort study located in Shenyang, China. Its initial aim is to facilitate research on understanding the interplay between genes and environmental factors on disease etiology. Data are collected regarding environmental factors, family and lifestyle, clinical experimental outcomes and imaging results of pregnant women and children from birth to 18 years old. Biological samples including blood and tissue samples are also collected from the children and their parents.

Eligibility Criteria

Inclusion Criteria: 1. Pregnant women, \<13 gestational weeks 2. Permanent residents or families intended to remain in Shenyang and surrounding areas 3. Pregnant women who are planned to be examined and delivered in Shengjing Hospital. Exclusion Criteria: 1. Pregnant women who refuse to take part in the study 2. Pregnant women have diseases that might affect the results of researches, including neuropsychiatric disorders.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology